GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Shree Ganesh Biotech (India) Ltd (BOM:539470) » Definitions » Altman Z-Score

Shree Ganesh Biotech (India) (BOM:539470) Altman Z-Score : 3.30 (As of Jun. 04, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Shree Ganesh Biotech (India) Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Good Sign:

Altman Z-score of 3.37 is strong.

Shree Ganesh Biotech (India) has a Altman Z-Score of 3.30, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Shree Ganesh Biotech (India)'s Altman Z-Score or its related term are showing as below:

BOM:539470' s Altman Z-Score Range Over the Past 10 Years
Min: 2   Med: 9.25   Max: 97.94
Current: 3.37

During the past 9 years, Shree Ganesh Biotech (India)'s highest Altman Z-Score was 97.94. The lowest was 2.00. And the median was 9.25.


Shree Ganesh Biotech (India) Altman Z-Score Historical Data

The historical data trend for Shree Ganesh Biotech (India)'s Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shree Ganesh Biotech (India) Altman Z-Score Chart

Shree Ganesh Biotech (India) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Altman Z-Score
Get a 7-Day Free Trial Premium Member Only 21.64 22.07 9.09 4.61 2.66

Shree Ganesh Biotech (India) Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.18 2.66 2.55 2.92 4.49

Competitive Comparison of Shree Ganesh Biotech (India)'s Altman Z-Score

For the Agricultural Inputs subindustry, Shree Ganesh Biotech (India)'s Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shree Ganesh Biotech (India)'s Altman Z-Score Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Shree Ganesh Biotech (India)'s Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Shree Ganesh Biotech (India)'s Altman Z-Score falls into.



Shree Ganesh Biotech (India) Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Shree Ganesh Biotech (India)'s Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.8216+1.4*0+3.3*0.0054+0.6*3.2872+1.0*0.3213
=3.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2023:
Total Assets was ₹761.6 Mil.
Total Current Assets was ₹761.6 Mil.
Total Current Liabilities was ₹135.8 Mil.
Retained Earnings was ₹0.0 Mil.
Pre-Tax Income was 0.869 + 0.751 + 1.494 + 0.964 = ₹4.1 Mil.
Interest Expense was 0 + 0 + 0 + 0 = ₹0.0 Mil.
Revenue was 41.225 + 41.181 + 82.538 + 79.775 = ₹244.7 Mil.
Market Cap (Today) was ₹446.5 Mil.
Total Liabilities was ₹135.8 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(761.602 - 135.819)/761.631
=0.8216

X2=Retained Earnings/Total Assets
=0/761.631
=0

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(4.078 - 0)/761.631
=0.0054

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=446.459/135.819
=3.2872

X5=Revenue/Total Assets
=244.719/761.631
=0.3213

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Shree Ganesh Biotech (India) has a Altman Z-Score of 3.30 indicating it is in Safe Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


Shree Ganesh Biotech (India)  (BOM:539470) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Shree Ganesh Biotech (India) Altman Z-Score Related Terms

Thank you for viewing the detailed overview of Shree Ganesh Biotech (India)'s Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Shree Ganesh Biotech (India) (BOM:539470) Business Description

Traded in Other Exchanges
N/A
Address
CUBICLE NO.:126,3/2 ,75C,PARK STREET, 3RD FLOOR, KAMDHENU BUILDING, Kolkata, WB, IND, 700016
Shree Ganesh Biotech (India) Ltd is an India based company mainly engaged in the trading of seeds. It is engaged in the business of production, processing and marketing of high quality hybrid seeds for different crops like corn, sunflower, cotton, paddy, grain sorghum.

Shree Ganesh Biotech (India) (BOM:539470) Headlines

No Headlines